Biofrontera (BFRI) Retained Earnings (2020 - 2026)
Biofrontera (BFRI) posted quarterly Retained Earnings of $138.4 million for Q4 2025, up 217.89% year-over-year from $43.5 million in Q4 2024, and up 5.67% quarter-over-quarter from $131.0 million in Q3 2025.
Biofrontera (BFRI) Retained Earnings (2020 - 2026) Analysis & Trends
Biofrontera's Retained Earnings history runs 6 years deep, the most recent figure standing at $138.4 million for Q4 2025.
- In Q4 2025, Retained Earnings rose 217.89% year-over-year to $138.4 million; the TTM figure through Dec 2025 stood at $138.4 million (up 217.89% YoY), while the FY2025 annual figure was $138.4 million, up 217.89% from the prior year.
- Retained Earnings for Q4 2025 stood at $138.4 million, up from $131.0 million in the prior quarter.
- The five-year high for Retained Earnings was $138.4 million in Q4 2025, with the low at -$126.9 million in Q2 2025.
- The 5-year median for Retained Earnings is -$64.4 million (2021), against an average of $976764.7.
- The sharpest annual moves came in 2021 and 2024: Retained Earnings soared 319.11% in 2021, then sank 212.42% in 2024.
- Biofrontera's Retained Earnings stood at $90.2 million in 2021, then slumped by 188.16% to -$79.5 million in 2022, then jumped by 231.34% to $104.4 million in 2023, then tumbled by 212.42% to -$117.4 million in 2024, then jumped by 217.89% to $138.4 million in 2025.
- Business Quant data shows BFRI's Retained Earnings at $138.4 million in Q4 2025, $131.0 million in Q3 2025, and -$126.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.36 Bn | 43.40 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.75 Bn | 40.09 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 32.42 Bn | 30.75 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.46 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.93 Bn | 18.05 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.46 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 3.75 Bn |
| 10 | Biofrontera | 19.32 Mn | 14.61 Mn | 9.59 Mn | 139.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 139.24 Mn |
| Dec 31, 2025 | 138.41 Mn |
| Sep 30, 2025 | 130.99 Mn |
| Jun 30, 2025 | -126.90 Mn |
| Mar 31, 2025 | 122.07 Mn |
| Dec 31, 2024 | -117.41 Mn |
| Sep 30, 2024 | -116.01 Mn |
| Jun 30, 2024 | -110.30 Mn |
| Mar 31, 2024 | 104.67 Mn |
| Dec 31, 2023 | 104.44 Mn |
| Sep 30, 2023 | -103.18 Mn |
| Mar 31, 2023 | 103.72 Mn |
| Dec 31, 2022 | -79.52 Mn |
| Sep 30, 2022 | -76.70 Mn |
| Jun 30, 2022 | -74.20 Mn |
| Mar 31, 2022 | 90.72 Mn |
| Dec 31, 2021 | 90.20 Mn |
| Sep 30, 2021 | -64.40 Mn |
| Dec 31, 2020 | -41.17 Mn |